Add Yahoo as a preferred source to see more of our stories on Google. Jan. 30—ALBANY — The Southwest Georgia Public Health District is training select Registered Nurses to perform Nexplanon insertions ...
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque Organon (NYSE: OGN), a ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Organon (NYSE:OGN) received ...
Clinical data support a 5-year duration for the Nexplanon implant, with no reported pregnancies during the extended 2-year study period. The Food and Drug Administration (FDA) has extended the ...
The birth control implant, brand name Nexplanon, is considered one of the most effective reversible contraceptive methods available. It provides protection from pregnancy for up to three years with a ...
JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US ...
NEXPLANON will only be available in the US through the NEXPLANON REMS program, which is planned to be available starting on February 23, 2026. Providers will have six months to enroll in the program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results